Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01054066 · ClinicalTrials.gov registry record · NA
Managing Chronic Kidney Disease in Eastern North Carolina
A NA study, sponsored by East Carolina University.
- Completed
- Registry status
- NA
- Development phase
- 1,257
- Enrollment target
NCT01054066: Completed NA study, sponsored by East Carolina University.
NCT01054066 is a NA study that has completed, run by East Carolina University. The registered enrollment target is 1,257 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01054066, a NA study, has completed, sponsored by East Carolina University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,257 participants
- Enrollment target
Study Summary
The purpose of this program is to educate primary care physicians in four underserved clinics in eastern North Carolina about chronic kidney disease.
Interventions
- BEHAVIORAL Chronic Kidney Disease Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,257 participants |
| Start Date | 2008-08 |
| Est. Completion | 2011-05 |
| Phase | NA |
What the finished NCT01054066 record still lists
NCT01054066 is an interventional study that assigns participants to a tested intervention. Its 1,257 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% lower).
The record links to 0 conditions, and to 1 intervention - of which Chronic Kidney Disease Education is the first listed.
NCT01054066 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01054066 about?
NCT01054066 is a clinical study titled "Managing Chronic Kidney Disease in Eastern North Carolina". The purpose of this program is to educate primary care physicians in four underserved clinics in eastern North Carolina about chronic kidney disease.
What is the current status of trial NCT01054066?
This trial is currently completed. It is a NA study. The enrollment target is 1,257 participants. The study started on 2008-08. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01054066?
The interventions under investigation include: Chronic Kidney Disease Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01054066?
This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01054066's enrollment target sits among peer trials
1,257 80th of 2000 higher than 1,921 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06712316 · 1,260 participants · Phase 2
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- NCT06812273 · 1,260 participants · NA
Mediators and Moderators of Auditory Training
- NCT06931340 · 1,260 participants · Phase 3
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- NCT06119581 · 1,264 participants · Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia